Listener Training for Parkinson's (NCT06815263)
Improve intelligibility of Parkinson speech
- Trial ID
- NCT06815263
- Official Title
- Listener Training for Improved Intelligibility of People With Parkinson's Disease
- Goal
- Improve intelligibility of Parkinson speech
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Utah State University
- Study Type
- INTERVENTIONAL
- Enrollment
- 360 participants
- Conditions
- Dysarthria, Hypokinetic
- Interventions
- Listener Training
Summary For Families
The goal is to help people with Parkinson's be better understood by training their conversation partners to recognize and manage the speech changes that make everyday conversation hard. The approach teaches listeners practical strategies like using context clues, asking targeted clarification questions, reducing background noise, and using visual or written cues so partners can follow speech more easily, without changing the person’s medications or the speaker’s voice. The study is looking for adults 18 and older with a medical diagnosis of Parkinson's and a speech diagnosis of dysarthria, who are primary English speakers and do not have severe cognitive impairment.
Locations
- Florida State University, Tallahassee, Florida, United States
- Utah State University, Logan, Utah, United States
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Listener Training. The goal is to help people with Parkinson's be better understood by training their conversation partners to recognize and manage the speech changes that make everyday conversation hard. The approach teaches listeners practical strategies like using context clues, asking targeted clarification questions, reducing background noise, and using visual or written cues so partners can follow speech more easily, without changing the person’s medications or the speaker’s voice. The study is looking for adults 18 and older with a medical diagnosis of Parkinson's and a speech diagnosis of dysarthria, who are primary English speakers and do not have severe cognitive impairment.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 3 years and 9 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This trial has 2 groups, and 1 is a sham (a pretend version of the procedure) group. Because assignment is random, you have about a 1 in 2 chance (roughly 50%) of being in the sham group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.